BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17275207)

  • 21. Breast conserving treatment versus modified radical mastectomy in Japanese patients with operable breast cancer.
    Noguchi M; Yagasaki R; Kawahara F; Minami M; Tsuyama H; Earashi M; Kinoshita K; Taniya T; Miwa K; Nishijima H; Takanaka T; Kawashima H; Takashima C; Kanno M; Nakamura S; Mizukami Y; Nonomura A; Michigishi T; Yokoyama K
    Int Surg; 1997; 82(3):289-94. PubMed ID: 9372377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer.
    Truong PT; Bernstein V; Lesperance M; Speers CH; Olivotto IA
    Am J Surg; 2006 Jun; 191(6):749-55. PubMed ID: 16720143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up.
    Jobsen JJ; van der Palen J; Ong F
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):115-22. PubMed ID: 18234450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient demographics and treatment for early breast cancer: an observational study.
    Osborn GD; Hodin M; Drew PJ; Fielder H; Vaughan-Williams E; Sweetland HM
    Breast; 2006 Jun; 15(3):377-81. PubMed ID: 16169221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer.
    Mahmood U; Morris C; Neuner G; Koshy M; Kesmodel S; Buras R; Chumsri S; Bao T; Tkaczuk K; Feigenberg S
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1387-93. PubMed ID: 22300561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years.
    van der Leest M; Evers L; van der Sangen MJ; Poortmans PM; van de Poll-Franse LV; Vulto AJ; Nieuwenhuijzen GA; Brenninkmeijer SJ; Creemers GJ; Voogd AC
    Cancer; 2007 May; 109(10):1957-64. PubMed ID: 17394192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma.
    van der Sangen MJ; van de Poll-Franse LV; Roumen RM; Rutten HJ; Coebergh JW; Vreugdenhil G; Voogd AC
    Eur J Surg Oncol; 2006 Feb; 32(1):34-8. PubMed ID: 16305821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.
    Harris EE; Hwang WT; Lee EA; Cengel KA; Feldman MD; Demichele A; Kao G; Solin LJ
    Breast J; 2006; 12(5):431-6. PubMed ID: 16958961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early ipsilateral breast tumor recurrences after breast conservation affect survival: an analysis of the National Cancer Institute randomized trial.
    Brooks JP; Danforth DN; Albert P; Sciuto LC; Smith SL; Camphausen KA; Poggi MM
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):785-9. PubMed ID: 15936560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT).
    Vu-Nishino H; Tavassoli FA; Ahrens WA; Haffty BG
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1040-7. PubMed ID: 15990007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional radiotherapy may improve outcomes in patients with early stage breast cancer undergoing breast conservation therapy.
    Mai GT; Choo E; Yang JL; Cooke B; Dumitru D; Lonergan D; Lewis CR
    Anticancer Res; 2007; 27(1B):647-52. PubMed ID: 17348455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up.
    Kreike B; Hart AA; van de Velde T; Borger J; Peterse H; Rutgers E; Bartelink H; van de Vijver MJ
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1014-21. PubMed ID: 18234444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A prospective multicenter clinical trial of breast conserving therapy for early breast cancer in China].
    Zhang BN; Shao ZM; Qiao XM; Li B; Jiang J; Yang MT; Wang S; Song ST; Zhang B; Yang HJ
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):680-4. PubMed ID: 16438891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up.
    Vujovic O; Cherian A; Yu E; Dar AR; Stitt L; Perera F
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):687-90. PubMed ID: 16949764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quality of life in relation to patient education regarding surgical procedures in primary breast carcinoma].
    Gerber B; Krause A
    Zentralbl Gynakol; 1997; 119(4):149-53. PubMed ID: 9206919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.
    Seynaeve C; Verhoog LC; van de Bosch LM; van Geel AN; Menke-Pluymers M; Meijers-Heijboer EJ; van den Ouweland AM; Wagner A; Creutzberg CL; Niermeijer MF; Klijn JG; Brekelmans CT
    Eur J Cancer; 2004 May; 40(8):1150-8. PubMed ID: 15110878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
    Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
    Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast-conserving therapy in young women with invasive carcinoma of the breast.
    Borg MF
    Australas Radiol; 2004 Sep; 48(3):376-82. PubMed ID: 15344990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.